Negara: Irlandia
Bahasa: Inggris
Sumber: HPRA (Health Products Regulatory Authority)
Paracetamol; Caffeine; Phenylephrine hydrochloride
Haleon Ireland Limited
N02BE; N02BE51
Paracetamol; Caffeine; Phenylephrine hydrochloride
500/25/5 milligram(s)
Film-coated tablet
Product not subject to medical prescription
Anilides; paracetamol, combinations excl. psycholeptics
Not marketed
1992-08-20
PANADOL SINUS RELIEF FILM COATED TABLETS Paracetamol 500mg Caffeine 25mg Phenylephrine Hydrochloride 5mg PLEASE READ RIGHT THROUGH THIS LEAFLET BEFORE YOU START USING THIS MEDICINE. This medicine is available without prescription, but you still need to use Panadol Sinus Relief tablets carefully to get the best results from them. • Keep this leaflet. You may need to read it again. • If you have any questions, or there is anything you do not understand, ask your pharmacist. IN THIS LEAFLET: 1. What Panadol Sinus Relief is and what it is used for 2. What you need to know before you take Panadol Sinus Relief 3. How to take Panadol Sinus Relief 4. Possible side effects 5. How to store Panadol Sinus Relief 6. Contents of the pack and further information 1. WHAT PANADOL SINUS RELIEF IS AND WHAT IT IS USED FOR Panadol Sinus Relief provide effective relief from the major cold and flu symptoms. These symptoms include headache, shivers, aches and pains, blocked nose and painful sinuses, catarrh, sore throat, fatigue and tiredness. Panadol Sinus Relief tablets contains three active ingredients. Paracetamol is a pain killer and reduces your temperature when you have a fever. Phenylephrine hydrochloride unblocks your nose and sinuses helping you breathe more easily. Caffeine is present as a mild stimulant which acts to further help the effectiveness of paracetamol. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PANADOL SINUS RELIEF DO NOT TAKE PANADOL SINUS RELIEF: • If you have ever had an allergic reaction to paracetamol, phenylephrine hydrochloride, caffeine or any of the other ingredients (listed in Section 6). • if you have severe kidney or severe liver problems, overactive thyroid, diabetes, phaeochromocytoma, enlarged prostate, glaucoma or are under the care of your doctor for high blood pressure or heart disease ‐if you are taking tricyclic antidepressants (e.g.imipramine or amitripyline) or have taken monoamine oxidase inhibitors (MAOIs) prescribed for depressions in the last two weeks ‐if you are taking beta bl Baca dokumen lengkapnya
Health Products Regulatory Authority 20 June 2023 CRN00DKSP Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Panadol Sinus Relief Film Coated TabletsParacetamol 500mgCaffeine 25mgPhenylephrine Hydrochloride 5mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film coated tablet contains paracetamol 500 mg, caffeine 25 mg and phenylephrine hydrochloride 5 mg. Excipients: also includes sunset yellow (E110), 0.62 mg per tablet. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet Orange film-coated tablet embossed with ‘B’ on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS The product is recommended for the relief of the symptoms of nasal and sinus congestion, colds and flus. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral administration only. Do not exceed the stated dose. The lowest dose necessary to achieve efficacy should be used for the duration of treatment. Should not be used with other paracetamol-containing products, decongestants, or cold and flu medicines. ADULTS (INCLUDING THE ELDERLY) AND CHILDREN AGED 16 YEARS AND OVER: One to two tablets every 4-6 hours as required. Maximum daily dose: Eight tablets in 24 hours. CHILDREN AGED 12 – 15 YEARS: One tablet every 4-6 hours as required. Maximum daily dose: four tablets in 24 hours. Not recommended for children under 12 years of age MINIMUM DOSING INTERVAL: 4 hours MAXIMUM DURATION OF CONTINUED USE WITHOUT MEDICAL ADVICE: 3 DAYS 4.3 CONTRAINDICATIONS Known hypersensitivity to paracetamol, phenylephrine, caffeine or any of the other ingredients listed in section 6.1. Use in children under 12 years of age. Health Products Regulatory Authority 20 June 2023 CRN00DKSP Page 2 of 8 Severe hepatic or severe renal impairment, hypertension, hyperthyroidism, diabetes, closed angle glaucoma, phaeochomocytoma, prostate hypertrophy and heart disease. Patients taking tricyclic antidepressants, or beta-blocking drugs and those who are taking or who have taken within the last two weeks monoamin Baca dokumen lengkapnya